Skip to main
IMAX

IMAX (IMAX) Stock Forecast & Price Target

IMAX (IMAX) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 33%
Buy 56%
Hold 11%
Sell 0%
Strong Sell 0%

Bulls say

Imax Corp has demonstrated resilience with a domestic screen base that has grown slightly since the pandemic, in contrast to a contraction in the overall industry screen base. The company is expected to achieve revenue growth of approximately 9% in 2026, reaching around $437 million, fueled by an increase in quality content, a growing market share, and alternative content opportunities. With a positive outlook on global box office performance, IMAX anticipates a 12% year-over-year increase in revenue from IMAX screens, which aligns with the trend of expanding local language titles and a broader spectrum of alternative content.

Bears say

The analysis indicates a negative outlook for Imax Corp, driven by significant challenges within the exhibition industry, where audience demand for premium film experiences is at risk due to potential shifts in film distribution models, particularly with competitors like Netflix exploring alternative release strategies. The recent decline in shares among theater exhibitors, coupled with concerns about box office performance, particularly as IMAX's threshold for box office success has been significantly lowered, suggests vulnerability in revenue streams. Additionally, the lingering effects of COVID-19 on the exhibition sector raise concerns about the sustainability of box office growth, ultimately impacting Imax's financial performance.

IMAX (IMAX) has been analyzed by 9 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 56% recommend Buy, 11% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IMAX and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IMAX (IMAX) Forecast

Analysts have given IMAX (IMAX) a Buy based on their latest research and market trends.

According to 9 analysts, IMAX (IMAX) has a Buy consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $41.89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $41.89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IMAX (IMAX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.